$POCI
Precision Optics Corporation Inc Stock $poci

$poci Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000168316824006760 Filed on September 30, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue		$4.716M	$19.10M
YoY Change		-6.05%	-9.22%
Cost Of Revenue		$3.692M	$13.31M
YoY Change		12.9%	-0.03%
Gross Profit		$1.024M	$5.798M
YoY Change		-41.79%	-25.04%
Gross Profit Margin		21.72%	30.35%
Selling, General & Admin		$2.026M	$7.540M
YoY Change		-0.67%	2.17%
% of Gross Profit		197.79%	130.06%
Research & Development		$354.5K	$981.8K
YoY Change		7.43%	-1.07%
% of Gross Profit		34.61%	16.93%
Depreciation & Amortization		$55.79K	$212.4K
YoY Change		11.58%	0.78%
% of Gross Profit		5.45%	3.66%
Operating Expenses		$2.381M	$8.522M
YoY Change		0.46%	1.78%
Operating Profit		-$1.356M	-$2.724M
YoY Change		122.35%	326.64%
Interest Expense		-$52.82K	-$225.1K
YoY Change		5.64%	-202.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$1.409M	-$2.949M
YoY Change		1465.74%	1967.22%
Income Tax		$1.940K	$1.936K
% Of Pretax Income
Net Earnings		-$1.411M	-$2.951M
YoY Change		1311.11%	1940.88%
Net Earnings / Revenue		-29.92%	-15.45%
Basic Earnings Per Share			-$0.49
Diluted Earnings Per Share		-$0.23	-$0.49
COMMON SHARES
Basic Shares Outstanding	6.350M shares	6.069M shares	6.068M shares
Diluted Shares Outstanding			6.068M shares

Balance Sheet

Concept	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$405.3K	$405.3K
YoY Change	-86.17%	-86.17%
Cash & Equivalents	$405.3K	$405.3K
Short-Term Investments
Other Short-Term Assets	$299.4K	$299.4K
YoY Change	19.74%	19.74%
Inventory	$2.868M	$2.868M
Prepaid Expenses	$299.4K
Receivables	$3.545M	$3.545M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.118M	$7.118M
YoY Change	-27.8%	-27.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$493.6K	$683.6K
YoY Change	13.85%	-13.47%
Goodwill	$8.824M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$9.794M	$9.794M
YoY Change	-0.88%	-0.87%
TOTAL ASSETS
Total Short-Term Assets	$7.118M	$7.118M
Total Long-Term Assets	$9.794M	$9.794M
Total Assets	$16.91M	$16.91M
YoY Change	-14.33%	-14.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.397M	$1.397M
YoY Change	-42.55%	-42.5%
Accrued Expenses	$1.019M	$1.019M
YoY Change	-7.35%	-7.35%
Deferred Revenue	$1.172M
YoY Change	-0.2%
Short-Term Debt	$1.000M	$1.000M
YoY Change
Long-Term Debt Due	$276.9K	$318.0K
YoY Change	-46.05%	-43.21%
Total Short-Term Liabilities	$4.907M	$4.907M
YoY Change	-6.71%	-6.71%
LONG-TERM LIABILITIES
Long-Term Debt	$1.899M	$1.926M
YoY Change	-12.73%	-14.0%
Other Long-Term Liabilities	$11.55K	$11.55K
YoY Change	-93.92%	-93.92%
Total Long-Term Liabilities	$1.899M	$1.938M
YoY Change	-12.73%	-20.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.907M	$4.907M
Total Long-Term Liabilities	$1.899M	$1.938M
Total Liabilities	$6.845M	$6.845M
YoY Change	-7.95%	-10.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.19M
YoY Change	6.12%
Common Stock	$60.74K
YoY Change	0.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.07M	$10.07M
YoY Change
Total Liabilities & Shareholders Equity	$16.91M	$16.91M
YoY Change	-14.33%	-14.32%

Cashflow Statement

Concept	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$1.411M	-$2.951M
YoY Change	1311.11%	1940.88%
Depreciation, Depletion And Amortization	$55.79K	$212.4K
YoY Change	11.58%	0.78%
Cash From Operating Activities	-$976.0K	-$2.683M
YoY Change	60.0%	3208.68%
INVESTING ACTIVITIES
Capital Expenditures	$11.80K	$272.4K
YoY Change		1523.18%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$11.80K	-$293.9K
YoY Change		459.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$513.3K
YoY Change		39.72%
Cash From Financing Activities	468.0K	$456.3K
YoY Change	-83.97%	-81.4%
NET CHANGE
Cash From Operating Activities	-976.0K	-$2.683M
Cash From Investing Activities	-11.80K	-$293.9K
Cash From Financing Activities	468.0K	$456.3K
Net Change In Cash	-519.8K	-$2.521M
YoY Change	-122.5%	-208.64%
FREE CASH FLOW
Cash From Operating Activities	-$976.0K	-$2.683M
Capital Expenditures	$11.80K	$272.4K
Free Cash Flow	-$987.8K	-$2.955M
YoY Change	61.94%	2919.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000867840
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-10647
CY2024	dei	Entity Registrant Name EntityRegistrantName	PRECISION OPTICS CORPORATION, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MA
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2795294
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	22 East Broadway
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Gardner
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01440
CY2024	dei	City Area Code CityAreaCode	978
CY2024	dei	Local Phone Number LocalPhoneNumber	630-1800
CY2024	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value
CY2024	dei	Trading Symbol TradingSymbol	POCI
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	27744000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6350170	shares
CY2024	dei	Auditor Firm AuditorFirmId	577
CY2024	dei	Auditor Name AuditorName	Stowe & Degon LLC
CY2024	dei	Auditor Location AuditorLocation	Westborough, Massachusetts
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	405278	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2925852	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	118872	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	606715	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3545491	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3907407	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2868100	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2776216	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	299364	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	249681	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	7118233	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	9859156	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3341194	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3227481	usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	810914	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	825752	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	416425	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	242865	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4568533	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4296098	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4074960	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3862578	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	493573	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	433520	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	189999	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	358437	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	286559	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	265111	usd
CY2024Q2	us-gaap	Goodwill Goodwill	8824210	usd
CY2023Q2	us-gaap	Goodwill Goodwill	8824210	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	9300768	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	9447758	usd
CY2024Q2	us-gaap	Assets Assets	16912574	usd
CY2023Q2	us-gaap	Assets Assets	19740434	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1000000	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	41113	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	43209	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	276928	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	513259	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1397313	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2432264	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1172350	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1174690	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	840662	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	927521	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	178450	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	168677	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4906816	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5259620	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	27369	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	68482	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1899052	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2175980	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11549	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189760	usd
CY2024Q2	us-gaap	Liabilities Liabilities	6844786	usd
CY2023Q2	us-gaap	Liabilities Liabilities	7693842	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6073939	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6073939	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6066518	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6066518	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	60739	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	60665	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61197433	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60224934	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51190384	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48239007	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10067788	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12046592	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16912574	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19740434	usd
CY2024	us-gaap	Revenues Revenues	19104350	usd
CY2023	us-gaap	Revenues Revenues	21044467	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	13306573	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	13310331	usd
CY2024	us-gaap	Gross Profit GrossProfit	5797777	usd
CY2023	us-gaap	Gross Profit GrossProfit	7734136	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	981781	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	992375	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7540329	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7380309	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	8522110	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	8372684	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2724333	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-638548	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	225108	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	218927	usd
CY2024	POCI	Gain On Revaluation Of Contingents Earnout Liabilities GainOnRevaluationOfContingentsEarnoutLiabilities	0	usd
CY2023	POCI	Gain On Revaluation Of Contingents Earnout Liabilities GainOnRevaluationOfContingentsEarnoutLiabilities	714798	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2949441	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-142677	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1936	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1936	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2951377	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144613	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068329	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6068329	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5666034	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5666034	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8971495	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2288282	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12396	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	919032	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144613	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12046592	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12789	usd
CY2024	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	2916	shares
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	0	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	959784	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2951377	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10067788	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2951377	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144613	usd
CY2024	POCI	Gain On Revaluation Of Contingent Earnout Liability GainOnRevaluationOfContingentEarnoutLiability	-0	usd
CY2023	POCI	Gain On Revaluation Of Contingent Earnout Liability GainOnRevaluationOfContingentEarnoutLiability	705892	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	212382	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	210735	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	959784	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	919032	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	17504	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4087	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-361916	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1243535	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	91884	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-245931	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	49683	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	36233	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1034951	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	193089	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2340	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	269577	usd
CY2024	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-104363	usd
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	206732	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2683012	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-81090	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21448	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	35713	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	272435	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16784	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-293883	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52497	usd
CY2024	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	43209	usd
CY2023	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	40705	usd
CY2024	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	513259	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	367341	usd
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	750000	usd
CY2024	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	22275	usd
CY2024	POCI	Payment Of Acquisition Earnout Liability PaymentOfAcquisitionEarnoutLiability	-0	usd
CY2023	POCI	Payment Of Acquisition Earnout Liability PaymentOfAcquisitionEarnoutLiability	166667	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1000000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2024	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2288281	usd
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12789	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12397	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	456321	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2453690	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2520574	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2320103	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2925852	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	605749	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	405278	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2925852	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	1936	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1936	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	reverse stock split on a one-for-three
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16915089	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5638302	shares
CY2024	us-gaap	Revenues Revenues	19104350	usd
CY2023	us-gaap	Revenues Revenues	21044467	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1174690	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	905113	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1946946	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2545317	usd
CY2024	POCI	Revenue Recognized RevenueRecognized	-1949286	usd
CY2023	POCI	Revenue Recognized RevenueRecognized	-2275740	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1172350	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1174690	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	405278	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2925852	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1570135	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1142816	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	157406	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	322538	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1140559	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1310862	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2868100	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2776216	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212382	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	210735	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zIwc2ZCP1JUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%; text-align: justify"><span style="font-size: 10pt"><b>(g)</b></span></td> <td style="width: 95%; text-align: justify"><span style="font-size: 10pt"><b><span id="xdx_868_zRwpArTTe9M6">Significant Customers and Concentration of Credit Risk</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that subject the Company to credit risk consist primarily of cash equivalents and trade accounts receivable. The Company places its investments with highly rated financial institutions. The Company has not experienced any losses on these investments to date. At June 30, 2024, and 2023, two individual customers accounted for more than <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zni2u6rqjBb3" title="Concentration risk percentage"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z2chGI4lSkug" title="Concentration risk percentage">10</span></span>% of the Company’s total accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The allowance for credit losses was $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20240630_zFhJCfzNDjS6">118,872 </span>at June 30, 2024, and $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20230630_z6xgX3ZxRerh">606,715 </span>at June 30, 2023.</p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_ziSloABPf73b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Allowance for credit losses)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B7_zrBadV6mukKg" style="display: none">Schedule of allowance for credit losses</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Year Ended June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Allowance for credit losses, beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20230701__20240630_zOs1dJZYVxWb" style="width: 13%; text-align: right" title="Allowance for credit losses, beginning of period">606,715</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20220701__20230630_zfqBp1CPA52" style="width: 13%; text-align: right" title="Allowance for credit losses, beginning of period">44,135</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in the provision for expected credit losses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ProvisionForDoubtfulAccounts_c20230701__20240630_zgrWKA9cjvHg" style="text-align: right" title="Change in the provision for expected credit losses">(23,541</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProvisionForDoubtfulAccounts_c20220701__20230630_zqNHCrJN0CJ8" style="text-align: right" title="Change in the provision for expected credit losses">567,066</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Writeoffs charged against the allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_c20230701__20240630_zHklsyQBPq4b" style="border-bottom: Black 1pt solid; text-align: right" title="Write offs charged against the allowance">(464,302</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_c20220701__20230630_z2NPlpsq3Gcc" style="border-bottom: Black 1pt solid; text-align: right" title="Write offs charged against the allowance">(4,847</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Allowance for credit losses, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20230701__20240630_zV3vrKUXzhSe" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for credit losses, end of period">118,872</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20220701__20230630_zEI2T3R8mB3b" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for credit losses, end of period">606,715</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zwhvQMyUEI9b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the year ended June 30, 2023, the Company increased the credit loss reserve to cover potential losses due to the insolvency of one customer and wrote off the receivable against the reserve during the year ended June 30, 2024. The Company generally does not require collateral or other security as a condition of sale, rather it relies on credit approval, balance limitation and monitoring procedures to control credit risk in trade account financial instruments. Management believes the allowance for credit losses, which is established based upon review of specific account balances and historical experience, is adequate at June 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	118872	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	606715	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	606715	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44135	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-23541	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	567066	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	464302	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4847	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	118872	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	606715	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2951377	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2951377	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-144613	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-144613	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068329	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6068329	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5666034	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5666034	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1357735	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1017041	shares
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	959784	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	919032	usd
CY2024	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zMf6padrmTe7" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"><span style="font-size: 10pt"><b>(p)</b></span></td> <td style="width: 95%"><span style="font-size: 10pt"><b><span id="xdx_86F_zSr85GPtUJo3">Use of Estimates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting standards generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024	POCI	Waiver Fee WaiverFee	5000	usd
CY2024Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1609524	usd
CY2024Q2	us-gaap	Loans Payable LoansPayable	600000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	276928	usd
CY2024Q2	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	14360	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	33544	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1899052	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	285097	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	594578	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	594578	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	594578	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	140693	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	2209524	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	189999	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	178450	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11549	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	959784	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	919032	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M18D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.994	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.019	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.69
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.77
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	420000	shares
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1936	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1936	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.063	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.058	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.163	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.233	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.105	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	1.760	pure
CY2024	POCI	Effective Income Tax Rate Reconciliation Nol Utilization EffectiveIncomeTaxRateReconciliationNOLUtilization	0	pure
CY2023	POCI	Effective Income Tax Rate Reconciliation Nol Utilization EffectiveIncomeTaxRateReconciliationNOLUtilization	0.050	pure
CY2024	POCI	Revaluation Of Contingent Earn Out Liability RevaluationOfContingentEarnOutLiability	0	pure
CY2023	POCI	Revaluation Of Contingent Earn Out Liability RevaluationOfContingentEarnOutLiability	-1.352	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.004	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.056	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3999000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2617000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	353000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	247000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	254000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	407000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4606000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3271000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4606000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3271000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2024	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-006760-index-headers.html	Edgar Link	pending
0001683168-24-006760-index.html	Edgar Link	pending
0001683168-24-006760.txt	Edgar Link	pending
0001683168-24-006760-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
poci-20240630.xsd	Edgar Link	pending
poci_ex0401.htm	Edgar Link	pending
poci_ex0402.htm	Edgar Link	pending
poci_ex1030.htm	Edgar Link	pending
poci_ex1031.htm	Edgar Link	pending
poci_ex1901.htm	Edgar Link	pending
poci_ex2301.htm	Edgar Link	pending
poci_ex3101.htm	Edgar Link	pending
poci_ex3102.htm	Edgar Link	pending
poci_ex3201.htm	Edgar Link	pending
poci_ex9701.htm	Edgar Link	pending
poci_i10k-063024.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
poci-20240630_cal.xml	Edgar Link	unprocessable
poci-20240630_def.xml	Edgar Link	unprocessable
poci-20240630_lab.xml	Edgar Link	unprocessable
poci-20240630_pre.xml	Edgar Link	unprocessable
poci_i10k-063024_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POCI
Precision Optics Corporation Inc Stock $poci

2024 Q3 Form 10-K Financial Statement

#000168316824006760 Filed on September 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POCI Precision Optics Corporation Inc Stock $poci

2024 Q3 Form 10-K Financial Statement

#000168316824006760 Filed on September 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POCI
Precision Optics Corporation Inc Stock $poci